← Open Payments lookup

SHILPA DIWAN: Open Payments

NPI 1942457999 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$737 in 35 payments from 11 companies in 2025. Trend: 2023 $219 · 2024 $443 · 2025 $737

Food & beverage: $737
CompanyPaymentsAmount
ABBVIE INC.11$242
Alkermes, Inc.4$76
Neurocrine BioSciences, Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.4$67
Supernus Pharmaceuticals, Inc.3$62
Tris Pharma Inc3$62
Axsome Therapeutics, Inc.2$53
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
E.R. Squibb & Sons, L.L.C.1$21
Lundbeck LLC1$19

Products named: VRAYLAR, ARISTADA, INGREZZA, TRINTELLIX, Dyanavel XR, Auvelity, CAPLYTA, REXULTI.

Industry payments across CA — which companies pay providers there.